Prevalence of arrhythmia-induced cardiomyopathy: A systematic review and meta-analysis

Teodor Serban1, Tatjana Müller1, Sven Knecht1

  • 1Department of Cardiology and Cardiovascular Research Institute Basel, University Hospital Basel, University of Basel, Basel, Switzerland.

Heart Rhythm
|December 6, 2025
PubMed

Insights

Arrhythmia-induced cardiomyopathy (AiCM) is a common cause of left ventricular systolic dysfunction (LVSD) in patients with arrhythmias, affecting 8% overall and 59% of those with LVSD. Standardized diagnostic criteria are needed for proper management.

Area of Science:

  • Cardiology
  • Internal Medicine

Background:

  • Arrhythmia-induced cardiomyopathy (AiCM) is a reversible cause of left ventricular systolic dysfunction (LVSD) linked to sustained cardiac arrhythmias.
  • Historically, AiCM has been underestimated, with its true prevalence remaining largely unknown.

Purpose of the Study:

  • To determine the prevalence of AiCM across diverse patient groups.
  • To analyze how baseline patient characteristics influence AiCM development.
  • To evaluate the diagnostic criteria employed in existing clinical research.

Main Methods:

  • A systematic review and meta-analysis adhering to PRISMA guidelines.
  • Searches conducted across PubMed, MEDLINE, and Embase databases.
  • Quality assessment using the Newcastle-Ottawa scale and RoBINS-I tool; meta-regression for prevalence factors.

Main Results:

  • 26 studies with 7331 patients were analyzed; overall AiCM prevalence was 8%, rising to 59% in LVSD cohorts.
  • Prevalence varied with arrhythmia type and diagnostic criteria.
  • Higher baseline heart rates and specific patient demographics (age, LVEF) were associated with AiCM.

Conclusions:

  • AiCM is the leading cause of LVSD in patients experiencing arrhythmias.
  • The findings underscore the critical need for uniform diagnostic standards to guide effective patient management.
Abstract

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
479
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
374
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
431
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
314
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
447